CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort study

Published:2021-05-06 Issue:6 Volume:31 Page:
ISSN:1015-6305
Container-title:Brain Pathology
language:en
Short-container-title:Brain Pathol.

Author:

Häusler Darius¹,Akgün Katja²,Stork Lidia¹,Lassmann Hans³^ORCID,Ziemssen Tjalf²,Brück Wolfgang¹,Metz Imke¹^ORCID

Affiliation:

1. Institute of Neuropathology University Medical Center Göttingen Germany

2. Department of Neurology Center of Clinical Neuroscience Carl Gustav Carus University ClinicUniversity Hospital of Dresden Dresden Germany

3. Center for Brain Research Medical University of Vienna Vienna Austria

Publisher

Wiley

Subject

Clinical Neurology,Pathology and Forensic Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bpa.12969

Reference49 articles.

1. Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

2. A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

3. Immune surveillance in multiple sclerosis patients treated with natalizumab

4. Altered CD4+/CD8+ T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis

5. Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CNS Resident Innate Immune Cells: Guardians of CNS Homeostasis;International Journal of Molecular Sciences;2024-04-29

2. Intruders or protectors – the multifaceted role of B cells in CNS disorders;Frontiers in Cellular Neuroscience;2024-01-10

3. Dendritic Cells as a Nexus for the Development of Multiple Sclerosis and Models of Disease;Advanced Biology;2023-05-03

4. Specific myeloid signatures in peripheral blood differentiate active and rare clinical phenotypes of multiple sclerosis;Frontiers in Immunology;2023-01-25

5. Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis;Journal of Neuroinflammation;2022-12-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3